Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0129 USD | -4.85% | -16.77% | -79.84% |
May. 16 | Transcript : Evofem Biosciences, Inc. - Special Call | |
May. 15 | Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 38
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Women Sexual and Reproductive Health
100.0
%
| 17 | 100.0 % | 18 | 100.0 % | +8.20% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 17 | 100.0 % | 18 | 100.0 % | +8.20% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 18-02-28 |
Amy Raskopf
IRC | Investor Relations Contact | - | 18-01-31 |
Human Resources Officer | - | 15-08-31 | |
Ellen Thomas
HRO | Human Resources Officer | - | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-12-31 |
Colin Rutherford
BRD | Director/Board Member | 65 | 17-12-31 |
Tony O'Brien
BRD | Director/Board Member | 61 | 18-01-16 |
Lisa Rarick
BRD | Director/Board Member | 64 | 20-02-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,921 | 0 | 0 | 100.00 % |
Stock B | 1 | 62,060,395 | 62,058,877 ( 100.00 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-80.47% | 1.02M | |
+43.28% | 750B | |
+34.11% | 606B | |
-6.73% | 356B | |
+19.03% | 326B | |
+6.64% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.05% | 167B |
- Stock Market
- Equities
- EVFM Stock
- Company Evofem Biosciences, Inc.